Back to results
US 2026/0263355 A1Published application
Drug-loaded pad for implanting on lymphatic tissue
OwnerJiang LIUinventor
Life of this patent
Estimating the term…
Abstract
A drug-loaded pad that is implanted onto target lymphatic tissue and in which the drug is released therefrom. The drug may be paclitaxel or docetaxel or cabazitaxel. The drug-loaded pad contains a therapeutically effective amount of the drug. The drug-loaded pad comprises a bulk matrix and drug particles carried by the bulk matrix. The bulk matrix comprises a biodegradable polymer. The drug-loaded pad may have a thickness of 2-8 mm. Also disclosed is a method of treating cancer in a patient comprising implanting the drug-loaded pad onto a target lymphatic tissue.
Claims20
A drug-loaded pad comprising:
- a bulk matrix comprising a biodegradable polymer;
- biodegradable drug particles carried by the bulk matrix, wherein the drug particles comprise a drug, wherein the drug is paclitaxel or docetaxel or cabazitaxel;
- wherein the drug constitutes 3-40 wt % of the drug-loaded pad.
Dependencies are inferred from the claim text.